Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (2009)
7 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, 2009
Slide 1: Consistent Growth Strategy
Consistent Growth Strategy US$M 300 • Innovative devices which improve care and outcomes 200 • Increase value per patient 100 • New patient groups • International expansion 0 FY04 FY05 FY06 FY07 FY08 FY09 1
Slide 2: Financial Highlights / Sales by Product Group
Financial Highlights • Exports 99% of sales • Operating revenue NZ$458.7M +28% • Net profit NZ$62.2M +76% • Operating margin 22% • R&D investment 6.2% of revenue 2 Sales by Product Group Distributed/ Other 3% OSA 44% Respiratory & Acute 53% ¯ Consumable and accessory products represent approx. 74% o
Slide 3: Sales by Region / Expanding International Presence
Sales by Region Asia Pacific/ Other 22% North America 45% Europe 33% Operating revenue 12 months to 31 March 2009 4 Expanding International Presence Europe Canada Asia Japan North America Middle East South America Australasia 5
Slide 4: Respiratory & Acute Care
Respiratory & Acute Care 6 Respiratory & Acute Care • 34% operating revenue growth • Humidifier controller placement driving breathing circuit market share • 24% of consumables revenue from new applications • Recently began international introduction of Airvo humidity therapy system 7
Slide 5: Obstructive Sleep Apnea
Obstructive Sleep Apnea 8 Obstructive Sleep Apnea • OSA treatment market growing rapidly • 23% operating revenue growth • Introduced premium flow generator range • Introduced Zest™ and Forma™ masks 9
Slide 6: Research & Development / Manufacturing Expansion
Research & Development • NZ$28M R&D investment +18% • New product pipeline includes: – myAirvo – Respiratory consumables – New Flow Generators NIVMask Mask myAirvo NIV myAirvo 10 Manufacturing Expansion • NZ$30M capex NZ • NZ$20M capex Mexico 11
Slide 7: Outlook
Outlook First Half • Operating revenue – NZ$245 million approx. • Profit after tax – NZ$37 million approx. Full Year • Profit after tax – NZ$75-80 million approx. (if average for remainder of year NZD:USD =0.67) 12
Fisher & Paykel Healthcare — Shareholder Meeting (2009) on 6ix